
    
      The objective of this trial is to determine whether Cetuximab and radiation preceded by an
      induction chemotherapy, may be superior to an established chemoradiation program for HNC
      (RTOG regimen, Adelstein DJ J.Clin.Oncol. 2003;21:92-98).
    
  